Description
Melanocortin agonist for hypoactive sexual desire disorder
PT-141, also known as Bremelanotide, is a peptide developed to support sexual health by enhancing arousal and boosting libido in both men and women. Acts directly on the central nervous system, stimulating neural pathways involved in sexual desire. Has demonstrated potential in addressing erectile dysfunction in men and arousal disorders in women. May also help elevate mood and lower stress, further supporting emotional and psychological wellness.
- Edinoff AN, et al. Bremelanotide for Treatment of Female Hypoactive Sexual Desire. Neurol Int. 2022;14(1):75-88. PMID: 35076581 | DOI: 10.3390/neurolint14010006
- Pettigrew JA, Novick AM. Hypoactive Sexual Desire Disorder in Women: Physiology, Assessment, Diagnosis, and Treatment. J Midwifery Womens Health. 2021;66(6):740-748. PMID: 34510696 | DOI: 10.1111/jmwh.13283
- Spielmans GI, Ellefson EM. Small Effects, Questionable Outcomes: Bremelanotide for Hypoactive Sexual Desire Disorder. J Sex Res. 2024;61(4):540-561. PMID: 36809187 | DOI: 10.1080/00224499.2023.2175192
